Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
07/2012
07/12/2012US20120178702 Stable lipid-comprising drug delivery complexes and methods for their production
07/12/2012US20120177743 Combinations and modes of administration of therapeutic agents and combination therapy
07/12/2012US20120177742 Nanoparticle and surface-modified particulate coatings, coated balloons, and methods therefore
07/12/2012US20120177741 Positively-charged poly (d,l-lactide-co-glycolide) nanoparticles and fabrication methods of the same
07/12/2012US20120177740 Drug delivery formulation for controlling of initial burst and manufacturing method thereof
07/12/2012US20120177739 Delayed Release Tablet with Defined Core Geometry
07/12/2012US20120177738 Green tea extracts of improved bioavailability
07/12/2012US20120177737 High drug load tablet
07/12/2012US20120177736 Method for treating a patient in need of aspirin therapy
07/12/2012US20120177735 Oral dosage formulation containing both immediate-release and sustained-release drugs for treating neurodegenerative disorders
07/12/2012US20120177734 Delayed Release Tablet with Defined Core Geometry
07/12/2012US20120177733 Solid dosage forms of valsartan and amlodipine and method of making the same
07/12/2012US20120177732 Concentration and mental performance amplifying formulation
07/12/2012US20120177731 Controlled release formulations of levodopa and uses thereof
07/12/2012US20120177730 Chemosensory Receptor Ligand-Based Therapies
07/12/2012US20120177729 Sustained release composition of ranolazine
07/12/2012US20120177728 Oxaliplatin nanoparticles and method for preparing same
07/12/2012US20120177727 Method and Apparatus for the Preparation of Capsules
07/12/2012US20120177726 Medical use of spla2 hydrolysable liposomes
07/12/2012US20120177725 Preparations for the external application of antiseptic agents and/or agents promoting the healing of wounds
07/12/2012US20120177724 Lipid vesicle compositions and methods of use
07/12/2012US20120177723 SiRNA PHOSPHOLIPID CONJUGATE
07/12/2012US20120177722 Lyaseenzymes, Nucleic Acids Encoding Them and Methods For Making and Using Them
07/12/2012US20120177721 Formulation
07/12/2012US20120177720 Multi-layer wound dressings
07/12/2012US20120177719 Medical device intended to come into contact with a patient's tissue and related manufacturing method
07/12/2012US20120177718 Wound-covering material
07/12/2012US20120177716 Methods for Making Controlled Delivery Devices Having Zero Order Kinetics
07/12/2012US20120177715 Heparin cofactor ii fragments with anti-inflammatory and anti-coagulant activity
07/12/2012US20120177708 Easily dispersible lipidic phase
07/12/2012US20120177706 Stable combinations of amlodipine besylate and benazepril hydrochloride
07/12/2012US20120177705 Composition 064
07/12/2012US20120177704 Crystalline anti-human il-12 antibodies
07/12/2012US20120177703 Solid linear oligo-or poly-e-caprolactone
07/12/2012US20120177702 Solid Forms for Tissue Repair
07/12/2012US20120177701 Compositions comprising immunostimulatory nucleic acids and related methods
07/12/2012US20120177700 Nanonized Iron Compositions and Methods of Use Thereof
07/12/2012US20120177699 Preparation Method of Drug Loaded Emulsion
07/12/2012US20120177698 Aggregates with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin
07/12/2012US20120177697 Excipients In Drug Delivery Vehicles
07/12/2012US20120177696 Diffusion-controlled dosage form and method of fabrication including three dimensional printing
07/12/2012US20120177695 Bioerodible Silicon-Based Devices for Delivery of Therapeutic Agents
07/12/2012US20120177694 Methods and Apparatus for Manufacturing Plasma Based Plastics and Bioplastics Produced Therefrom
07/12/2012US20120177693 Deep lung pulmonary delivery of treprostinil
07/12/2012US20120177692 Delivery systems for solubilising water-insoluble pharmaceutical active ingredients
07/12/2012US20120177620 Probiotic, Lactic Acid-Producing Bacteria
07/12/2012US20120177583 Compositions for anorectal use and methods for treating anorectal disorders
07/12/2012US20120177582 Compositions for anorectal use and methods for treating anorectal disorders
07/12/2012US20120177575 Fas (apo-1,cd95) targeted platforms for intracellular drug delivery
07/12/2012US20120177574 Microvesicles derived from nucleated, mammalian cells and use thereof
07/12/2012CA2834968A1 Methods of making liposomes, liposome compositions made by the methods, and methods of using the same
07/12/2012CA2823747A1 Liposome formulation suitable for treating or preventing tuberculosis
07/12/2012CA2823736A1 Compositions comprising and methods of using inhibitors of sodium-glucose cotransporters 1 and 2
07/12/2012CA2823628A1 Spray drying vancomycin
07/12/2012CA2823616A1 Immunosuppressant formulations
07/12/2012CA2822683A1 Bepotastine compositions
07/12/2012CA2822300A1 Compositions and methods of aloe polysaccharides
07/12/2012CA2819988A1 O/w-emulsions comprising semifluorinated alkanes
07/12/2012CA2819234A1 Pharmaceutical compositions of iron for oral administration
07/11/2012EP2474582A1 Coating agent comprising hydroxyalkyl cellulose
07/11/2012EP2474559A1 Hydroxypropyl cellulose particles
07/11/2012EP2474351A1 Apparatus and method for production of liposomes
07/11/2012EP2474324A1 Coating composition
07/11/2012EP2474314A1 Antiphlogistic, antioncotic and analgesic chinese herbal composition preparative method and usage thereof
07/11/2012EP2474312A1 Means for topical treatment of skin ailments
07/11/2012EP2474309A1 Pharmaceutical composition comprising ibuprofen, tramadol and a basic amino acid, preparation method thereof and use of same
07/11/2012EP2474308A1 Pharmaceutical formulations containing bupropion hydrobromide
07/11/2012EP2474307A2 Proliposomal drug delivery system
07/11/2012EP2474306A1 Particle composition and medicinal composition comprising same
07/11/2012EP2474305A2 Drug Delivery Implants, Systems and Methods for Making
07/11/2012EP2474298A1 Novel liquid crystal composition
07/11/2012EP2474294A1 Preparation for oral administration
07/11/2012EP2473475A1 Use of cannabidiol prodrugs in topical and transdermal administration with microneedles
07/11/2012EP2473266A1 Method and apparatus for preparing micro-particles of polysaccharides
07/11/2012EP2473247A2 Method of controlling crystallisation
07/11/2012EP2473195A2 Gastric retentive pharmaceutical compositions for immediate and extended release of acetaminophen
07/11/2012EP2473182A2 Targeted delivery using tissue-specific peptidomimetic ligands
07/11/2012EP2473179A1 Nigella extracts for the treatment of symptoms connected to impaired or imbalanced neurotransmission
07/11/2012EP2473178A2 Composition for the treatment of hemorrhoids and related diseases
07/11/2012EP2473174A2 Ganglioside transmucosal formulations
07/11/2012EP2473170A1 Use of aerosolized levofloxacin for treating cystic fibrosis
07/11/2012EP2473168A1 Pharmaceutical formulations for indibulin
07/11/2012EP2473163A2 Scented capsules
07/11/2012EP2473161A2 Topical formulations comprising a steroid
07/11/2012EP2473160A1 Delivery of therapeutic agents using oligonucleotide-modified nanoparticles as carriers
07/11/2012EP2473159A2 A composition for delaying cellular senescence
07/11/2012EP2473158A2 Composition
07/11/2012EP2473157A1 Ketorolac tromethamine compositions for treating or preventing ocular pain
07/11/2012EP2473143A1 Pulsatile release of medicaments from a punctal plug
07/11/2012EP2473095A1 Oral dosage form, comprising at least one biologically active agent, formulation auxiliary substances and magnetizable particles
07/11/2012EP2473044A1 Tocotrienol compositions
07/11/2012EP2293785B1 Nanoparticles containing a peptide, vectors containing the same and pharmaceutical uses of said nanoparticles and said vectors
07/11/2012EP2285349B1 Perfluorcarbon nanoemulsions with endocytosis enhancing surface for gene-transfer
07/11/2012EP2114531B1 Punctal plugs and methods of delivering therapeutic agents
07/11/2012EP2059206B8 Dry wound dressing and drug delivery system
07/11/2012EP1986613B1 Microtablet-based pharmaceutical preparation
07/11/2012EP1919458B1 Enterically coated cysteamine, cystamine and derivatives thereof
07/11/2012EP1915156B1 Use of psychomotor stimulants and compositions containing them in a method of treating parturient placental mammals in order to reduce maternal and/or uterine exhaustion
07/11/2012EP1793809B1 Modified release ibuprofen dosage form
07/11/2012EP1767216B1 Drug having regulatory cell ligand contained in liposome
1 ... 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 ... 2991